Johnell, Olof; Jonsson, Bengt; Jonsson, Linus; Black, Dennis - In: PharmacoEconomics 21 (2003) 5, pp. 305-314
Background: The Fracture Intervention Trial (FIT) demonstrated that the bisphosphonate alendronate reduces the risk of hip, spine and wrist fracture in osteoporotic women by approximately one half. Objective: To use data from FIT to conduct a cost-effectiveness analysis of alendronate. Design: A...